Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

被引：0
|
作者：
Wim A. Wuyts
Caroline Dahlqvist
Hans Slabbynck
Marc Schlesser
Natacha Gusbin
Christophe Compere
Sofie Maddens
Yuan-Chi Lee
Klaus-Uwe Kirchgaessler
Karen Bartley
Benjamin Bondue
机构：
[1] University Hospitals Leuven,Department of Respiratory Medicine, Unit for Interstitial Lung Diseases
[2] CHU UCL Namur Site Godinne,Department of Respiratory Medicine
[3] ZNA Middelheim,Department of Respiratory Medicine
[4] Centre Hospitalier de Luxembourg,Department of Respiratory Medicine
[5] CHR de la Citadelle,undefined
[6] CHIREC Hospital,undefined
[7] AZ Groeninge,undefined
[8] Genentech,undefined
[9] Inc.,undefined
[10] F. Hoffmann-La Roche,undefined
[11] Ltd.,undefined
[12] Erasme University Hospital,undefined
来源：
Respiratory Research | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Real-World Comprehensive Disease Management of Patients with Idiopathic Pulmonary Fibrosis
    Mason, Wendi
    McLaughlin, Sally
    Dedopoulos, Sophy
    Mahoney, Erin
    Meado, Tonja S.
    Stauffer, John L.
    Lancaster, Lisa H.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (01) : 4 - 15
  • [22] Real-World Data on the Course of Idiopathic Pulmonary Fibrosis
    Nathan, Steven D.
    Lee, Joyce S.
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (07): : S107 - S113
  • [23] Longitudinal Changes in Quality of Life in Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in the PROOF Registry
    Wuyts, W.
    Dahlqvist, C.
    Slabbynck, H.
    Schlesser, M.
    Gusbin, N.
    Compere, C.
    Maddens, S.
    Kirchgaessler, K.
    Bartley, K.
    Bondue, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience
    Nayci, Sibel
    Polat, Demet
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [25] Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort
    Durheim, Michael T.
    Bendstrup, Elisabeth
    Carlson, Lisa
    Sutinen, Eva M.
    Hyldgaard, Charlotte
    Kalafatis, Dimitrios
    Myllarniemi, Marjukka
    Skold, C. Magnus
    Sjaheim, Tone
    RESPIROLOGY, 2021, 26 (10) : 982 - 988
  • [26] Real-world cohort evaluation of the impact of the antifibrotics in patients with idiopathic pulmonary fibrosis
    Dempsey, Timothy M.
    Thao, Viengneesee
    Helfinstine, David A.
    Chang, Yu-Hui H.
    Sangaralingham, Lindsey
    Limper, Andrew H.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (04)
  • [27] Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
    Fournier, Dorine
    Jouneau, Stephane
    Bouzille, Guillaume
    Polard, Elisabeth
    Osmont, Marie-Noëlle
    Scailteux, Lucie-Marie
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 76
  • [28] Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
    Fournier, D.
    Jouneau, S.
    Bouzille, G.
    Polard, E.
    Osmont, M. N.
    Scailteux, L. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 77 - 78
  • [29] A Real-world Study of Patients With Combined Idiopathic Pulmonary Fibrosis and Lung Cancer
    Zhao, M.
    Zhang, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [30] Antifibrotic Persistence in Idiopathic Pulmonary Fibrosis: A Real-World Experience of 447 Patients
    Thillai, M.
    Harris, E.
    Harding, K.
    Babu, A.
    Verghese, P.
    Fiddler, C.
    Simler, N.
    Parfrey, H.
    Shah, R.
    McLellan, T.
    Atkins, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345